TP53 and metabolic dysfunction-associated steatohepatitis: 66 gene sets were down-regulated among NASH, NASH-CH, and human steatosis including: several metabolism pathways, the cell cycle, p53 DNA damage response, and telomere maintenance (Figure S3B).